Commitments and Contingencies (Tables)

6 Months Ended

Jun. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Schedule of Manufacturing Commitments and Contingencies

The following table summarizes manufacturing commitments and contingencies as of the period indicated (in thousands):

	June 30, 2024
Molgramostim manufacturer:
Achievement of certain milestones related to validation of API and regulatory approval of     molgramostim	$	1,300
Molgramostim nebulizer manufacturer:
Achievement of various development activities and regulatory approval of nebulizer utilized to administer molgramostim		536
Total manufacturing and other commitments and contingencies	$	1,836